secwatch.observer — SEC 8-K summary
======================================

Issuer:     GLOBUS MEDICAL INC (GMED)
CIK:        0001237831
Form:       8-K
Filed at:   2022-06-03T23:59:59+00:00
Accession:  0001562762-22-000267
Event type: other_material
Sentiment:  neutral
Materiality: 0.40
Item codes: 5.02, 5.07, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Globus Medical stockholders approve 2021 Equity Incentive Plan amendment at annual meeting
--------------------------------------------------------------------------------

- At June 2, 2022 annual meeting, stockholders voted to approve amendment to the 2021 Equity Incentive Plan, effective immediately.
- Directors David C. Paul, Daniel T. Lemaitre, and Ann D. Rhoads elected to three-year terms with strong stockholder support.
- Deloitte & Touche LLP ratified as independent registered public accounting firm for fiscal 2022 (295,235,366 for).
- Non-binding advisory vote on named executive officer compensation approved (283,414,921 for).
- Plan amendment details (including share reserves, vesting, and award types) incorporated by reference from proxy statement filed April 21, 2022.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1237831/000156276222000267/0001562762-22-000267-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1237831/000156276222000267/gmed-20220602x8k.htm
  HTML page:      https://secwatch.observer/filing/0001562762-22-000267

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer